Skip to evidence report

Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.

Tissue: Spinal cord: cell membership

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

Scope ID: tissue.SPC · tissue

All-cell scope membership reference

Cell-identity scopes include only populations at the same or a finer hierarchy level: parent populations do not list their child identity scopes. Overview, tissue, system, lineage and theme scopes use positive full-cell overlap; overlap does not imply that a population is wholly contained in that scope. Membership uses canonical names and levels from the full atlas, never sampled UMAP cells or legacy scoped aliases. Counts below are full-atlas population counts, not scope-local counts. Scope membership does not recompute or change the all-tissue ranking scores.

Type (L1)

5 canonical populations.

Tissue: Spinal cord — Type (L1)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
astrocyte12,592All scopes2561,203
endothelial_cell86,751All scopes373974
microglia3,933All scopes61129
oligodendrocyte46,264All scopes3851,507
oligodendrocyte_precursor_cell5,141All scopes4611,454

Subtype (L1S)

8 canonical populations.

Tissue: Spinal cord — Subtype (L1S)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
ASTRO.astrocyte12,592All scopes2281,111
EC.arterial18,254All scopes356885
EC.capillary25,638All scopes5141,635
EC.heart_remodeling10,813All scopes5691,594
EC.venous25,299All scopes5161,387
MG.microglia3,933All scopes490
OLG.oligodendrocyte46,264All scopes3841,397
OPC.oligodendrocyte_precursor_cell5,141All scopes4131,269

State (L2)

35 canonical populations.

Tissue: Spinal cord — State (L2)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
ASTRO.A1_reactive2,169All scopes433394
ASTRO.A2_reactive871All scopes1037
ASTRO.homeostatic2,197All scopes200431
ASTRO.hypoxia_angiogenic595All scopes518
ASTRO.immature_lipid1,128All scopes23113
ASTRO.neuromodulatory1,219All scopes34172
ASTRO.stress_acute1,372All scopes6056
ASTRO.stress_mito775All scopes47110
ASTRO.synaptic_interaction2,266All scopes76334
EC.arterial.arteriole_gas_exchange4,343All scopes238131
EC.arterial.arteriole_interface2,243All scopes3112
EC.arterial.homeostatic2,815All scopes243
EC.arterial.inflammatory1,659All scopes6350
EC.arterial.metabolic2,790All scopes195159
EC.capillary.angiocrine4,079All scopes250630
EC.capillary.baseline8,186All scopes246560
EC.capillary.inflammatory3,893All scopes2751
EC.capillary.migratory1,870All scopes181509
EC.capillary.stress2,762All scopes4436
EC.heart_remodeling.capillary_metabolic529All scopes54414
EC.venous.baseline15,775All scopes346807
EC.venous.remodeling_stalk1,326All scopes559566
MG.baseline2,106All scopes165
MG.expanding649All scopes21
MG.phagocytic_APC1,178All scopes258
OLG.myelinating_mature15,136All scopes36394
OLG.myelinating_stress4,537All scopes23262
OLG.reactive_repair3,037All scopes385385
OLG.regulatory10,882All scopes35373
OLG.regulatory_activated2,602All scopes196614
OLG.stress7,400All scopes2328
OLG.vesicle_trafficking2,670All scopes12410
OPC.homeostatic1,964All scopes394160
OPC.premyelinating1,832All scopes18512
OPC.proliferative_immune_interact1,345All scopes180373

Membership reference version: 9b81aedc7b46066c709a4506c6c8d91ddea39c9faadf291d1f387158f8a904f7